Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers

NCT: NCT07857655 · RECRUITING

NCT IDNCT07857655
StatusRECRUITING
Start Date2026-09-22
Completion2029-07-29
SponsorOHSU Knight Cancer Institute (OTHER)
First posted
Last updated

Brief Summary

This phase IV trial compares how well methadone plus standard fentanyl given during surgery (intraoperative) works compared to intraoperative standard fentanyl alone in managing pain after surgery (postoperative) among patients with head and neck cancers. For most head and neck cancers, the standard treatment is surgery to remove the cancer followed by surgical reconstruction, which often requires tissue harvested from another part of the body-known as a "free flap tissue transfer". These procedures are highly complex, demand a two-surgeon team, and often take many hours to complete. The combination of multiple operative sites and extent of the surgery contributes to significant postoperative pain. Methadone is not yet used in the head and neck population but has been utilized in other subspecialties like spine and cardiac surgery. The benefits of methadone may include improved pain control in the first 72 hours postoperatively requiring less opioids postoperatively and improvement in overall pain scores. Giving intraoperative methadone plus standard fentanyl may work better than fentanyl alone in managing postoperative pain among patients with head and neck cancers.

Frequently Asked Questions

What is Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers?

Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers is a clinical trial registered under NCT07857655. Current status: RECRUITING.

What is the status of NCT07857655?

The current status of NCT07857655 (Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers) is: RECRUITING.

When did Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers start?

Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers started on 2026-09-22.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑